Back
Royal Bank of Canada Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Buy
73
RY
Royal Bank of Canada
Last Price:
$125.18
Seasonality Move:
1.65%
Buy
55
RYTM
Rhythm Pharmaceuticals
Last Price:
$60.48
Seasonality Move:
84.98%
Buy
73
Royal Bank of Canada (RY)
is a Buy
Is Royal Bank of Canada a Buy, Sell or Hold?
-
The current Royal Bank of Canada [RY] share price is $124.78. The Score for RY is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
-
RY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
55
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals [RYTM] share price is $60.18. The Score for RYTM is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RY Stock Price Chart
What is Royal Bank of Canada's stock price today?
-
The Royal Bank of Canada share price today is $124.78Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RY is experiencing buying pressure, which is a positive indicator for future bullish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $60.18The current trend is relatively stagnant and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.
RY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.95 | Buy |
Relative Strength Index (14 RSI): | 72.52 | Buy |
Chaikin Money Flow: | 1582361 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (115.36 - 121.68) | Buy |
Bollinger Bands (100): | (114.19 - 121.63) | Buy |
RYTM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.24 | Buy |
Relative Strength Index (14 RSI): | 50.66 | Buy |
Chaikin Money Flow: | 683641 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (58.79 - 63.99) | Sell |
Bollinger Bands (100): | (52.97 - 60.83) | Buy |
RY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 121.3 | Buy |
20-day SMA: | 119.68 | Buy |
50-day SMA: | 115.81 | Buy |
200-day SMA: | 119.16 | Buy |
8-day EMA: | 121.8 | Buy |
20-day EMA: | 119.77 | Buy |
50-day EMA: | 117.94 | Buy |
200-day EMA: | 116.27 | Buy |
RYTM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 59.83 | Buy |
20-day SMA: | 61.69 | Sell |
50-day SMA: | 57.05 | Buy |
200-day SMA: | 54.4 | Buy |
8-day EMA: | 59.69 | Buy |
20-day EMA: | 60.27 | Sell |
50-day EMA: | 58.68 | Buy |
200-day EMA: | 53.81 | Buy |
Royal Bank of Canada Earnings Growth & RY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.14 per share, an increase next quarter of $0.20 per share, an increase this year of $0.99 per share, and an increase next year of $0.70 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.17 per share, an increase this year of $1.44 per share, and an increase next year of $1.20 per share.
Royal Bank of Canada Technical Analysis
May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Rhythm Pharmaceuticals Technical Analysis
May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |